Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Head and Neck Cancer

  Free Subscription


10.08.2026

1 BMC Cancer
3 Cancer Res
6 Clin Nucl Med
1 Dis Esophagus
16 Head Neck
1 Histopathology
2 Hum Pathol
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Laryngol Otol
1 J Nucl Med
1 J Oral Maxillofac Surg
5 Oral Oncol
3 Otolaryngol Head Neck Surg
1 Proc Natl Acad Sci U S A
2 Radiother Oncol
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. MAO Y, Gao Z, Sun Y, Shao C, et al
    Correction: Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma.
    BMC Cancer. 2026;26:913.
    PubMed        


    Cancer Res

  2. WU L, Ren C, Zhang Y, Wang G, et al
    Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2026 Aug 6. doi: 10.1158/0008-5472.CAN-25-5396.
    PubMed         Abstract available

  3. ZHANG Z, Liu F, Wang P, Wang T, et al
    Chronic Stress-Induced m7G Cap Modification of ADRB2 Dysregulates the Pentose Phosphate Pathway to Promote Esophageal Squamous Cell Carcinoma Progression.
    Cancer Res. 2026 Aug 5. doi: 10.1158/0008-5472.CAN-25-5775.
    PubMed         Abstract available

  4. XU T, Luo X, Lin M, Xu JJ, et al
    Phase Separation of ZBED2 Stabilizes ILK to Drive Metastasis and Immune Evasion in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2026 Aug 5. doi: 10.1158/0008-5472.CAN-25-5920.
    PubMed         Abstract available


    Clin Nucl Med

  5. XIAO L, Chang W, Feng H, Yao X, et al
    Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer: A Real-Life Multicenter Study.
    Clin Nucl Med. 2026 Jul 6. doi: 10.1097/RLU.0000000000006547.
    PubMed         Abstract available

  6. SUN G, Cao N, Shu Q, Feng Y, et al
    18F-FCH PET/CT Localizes Ectopic Parathyroid Adenoma.
    Clin Nucl Med. 2026 Jul 7. doi: 10.1097/RLU.0000000000006598.
    PubMed         Abstract available

  7. ELAHIFARD H, Samadi MH, Saberifar M, Makhdoumi Y, et al
    Theranostic Application of FAPI in Advanced Laryngeal Squamous Cell Carcinoma: 99mTc-FAPI-46 SPECT/CT Guided 177Lu-FAPI-2286 Therapy.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006505.
    PubMed         Abstract available

  8. SABER TANHA A, Aryana K, Zahed Anaraki S, Askari E, et al
    99m Tc-FAPI-46 Scintigraphy in Parotid Mucoepidermoid Carcinoma.
    Clin Nucl Med. 2026;51:e832-e833.
    PubMed         Abstract available

  9. VIOHL N, Seifert P, Drescher R, Freesmeyer M, et al
    F-18-DOPA-accumulating Meningioma Suspicious for an Intracranial Metastasis of Medullary Thyroid Cancer.
    Clin Nucl Med. 2026 Mar 31. doi: 10.1097/RLU.0000000000006439.
    PubMed         Abstract available

  10. JAMWAL A, Mahdi RA, Satapathy S, Aggarwal P, et al
    Iodine Avid Muscle Metastases Mimicking Skeletal Lesions on Whole-Body Iodine Scan in Poorly Differentiated Thyroid Carcinoma -SPECT/CT to the Rescue.
    Clin Nucl Med. 2026 Jul 21. doi: 10.1097/RLU.0000000000006632.
    PubMed         Abstract available


    Dis Esophagus

  11. NOMURA M, Bronzwaer SFC, Kroese TE, van Rossum PSN, et al
    Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes.
    Dis Esophagus. 2026;39:doag078.
    PubMed         Abstract available


    Head Neck

  12. TIGHE DG, Venchiarutti R, Ruisi I, Sundaresan P, et al
    Current Evidence on Best Practice Dental Survivorship Care for People With Head and Neck Cancer: An Overview of Systematic Reviews and Emerging Evidence.
    Head Neck. 2026 Aug 3. doi: 10.1002/hed.70409.
    PubMed         Abstract available

  13. YE L, He X, Liang M, Wei Y, et al
    Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Arterial Enhancement Fraction Derived From Dual-Layer Spectral CT.
    Head Neck. 2026 Aug 6. doi: 10.1002/hed.70424.
    PubMed         Abstract available

  14. WANG A, Akerman M, Singh A, Sharma K, et al
    Radiation Therapy and Overall Survival in Perineural Invasion-Positive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Head Neck. 2026 Aug 8. doi: 10.1002/hed.70421.
    PubMed         Abstract available

  15. MASSARELLI O, Frosolini A, Benedetti S, d'Arpa S, et al
    The Submandibular-Facial Artery Perforator Flap (S-FAPF): A Novel Tool for Lower Face Reconstruction.
    Head Neck. 2026;48:E87-E93.
    PubMed         Abstract available

  16. WILLIAMS LC, Lorenzo N, Ladenheim A, Mehra S, et al
    Biomarkers Associated With Extranodal Extension (ENE) in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Systematic Review.
    Head Neck. 2026;48:2329-2340.
    PubMed         Abstract available

  17. BELLAMKONDA N, Khurana N, Babajanian E, Ghandehari H, et al
    Intraoperative Indocyanine Green Fluorescence Enables Primary Tumor Localization and Treatment De-Escalation in SCCUP: A Case Report.
    Head Neck. 2026;48:E94-E99.
    PubMed         Abstract available

  18. THOIDINGJAM S, Sriramulu S, Muratoglu AH, Brown S, et al
    AKT, ATR, and Notch Inhibitors Radiosensitize a Preclinical Model of Adenoid Cystic Carcinoma.
    Head Neck. 2026;48:2364-2376.
    PubMed         Abstract available

  19. LI L, Wang W, Kou X, London NR Jr, et al
    Endoscopic Transoral Approach to the Upper Parapharyngeal Space: A Cadaveric and Clinical Applicability Study.
    Head Neck. 2026;48:2434-2441.
    PubMed         Abstract available

  20. SATURNO MP, First O, Shaari D, Guda R, et al
    Is There an Ideal Method of Predicting Postoperative Complications Following Major Head and Neck Procedures?: A Comparative Analysis of Three Frailty Indices.
    Head Neck. 2026;48:2404-2416.
    PubMed         Abstract available

  21. PIBER LS, Nakano LCU, Flumignan CDQ, Flumignan RLG, et al
    Computer-Aided Diagnosis in the Evaluation of Thyroid Nodules: A Study of Intra- And Inter-Rater Reliability and Agreement.
    Head Neck. 2026;48:2456-2469.
    PubMed         Abstract available

  22. KAHLOON L, Ishteiwy R, Gupta T, Albert C, et al
    Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review.
    Head Neck. 2026;48:2491-2498.
    PubMed         Abstract available

  23. TASEEN S, Qureshi MFH, Abbas M, Ghaloo SK, et al
    Oncological Safety of the Submental Artery Island Flap for Oral Reconstruction: A Systematic Review and Meta-Analysis.
    Head Neck. 2026;48:2470-2482.
    PubMed         Abstract available

  24. OMURA K, Terazawa K, Nomura K, Aoki S, et al
    Outcomes Following en Bloc Resection of Olfactory Neuroblastoma.
    Head Neck. 2026;48:2521-2528.
    PubMed         Abstract available

  25. SHANNON NB, Ashford B
    Integrating Immunotherapy Into Head and Neck Surgery: Bridging Tumor Biology to Perioperative Decision-Making, a Review.
    Head Neck. 2026;48:2570-2583.
    PubMed         Abstract available

  26. STROJAN P, Eisbruch A, Corry J, Nuyts S, et al
    Non-Metastatic Squamous Cell Carcinoma of the Oropharynx: Primary Surgery or (Chemo)radiotherapy?
    Head Neck. 2026;48:2541-2556.
    PubMed         Abstract available

  27. DA SILVA-FILHO JE, Ribeiro RR, de Aguiar AWO, Silva CM, et al
    Artificial Intelligence-Driven MRI for Cervical Nodal Metastasis Detection in Oral Squamous Cell Carcinoma: A Hierarchical Meta-Analysis of Diagnostic Accuracy.
    Head Neck. 2026;48:2557-2569.
    PubMed         Abstract available


    Histopathology

  28. ALFONSO-ROSA C, Machuca-Aguado J, Gonzalez-Suarez M, Conde-Martin AF, et al
    Mucinous adenocarcinoma of minor salivary gland with IPMN-like features.
    Histopathology. 2026;89:426-428.
    PubMed         Abstract available


    Hum Pathol

  29. LAOHAWETWANIT T, Dixit S, Agarwal S, Yoshikawa AL, et al
    Evaluating the diagnostic performance of multimodal large language models in thyroid cytology.
    Hum Pathol. 2026;175:106156.
    PubMed         Abstract available

  30. STRACCIA P, Fiorentino V, Urtueta BP, Zhang Q, et al
    Risk of malignancy in PTEN-altered thyroid nodules detected on preoperative FNA molecular testing: a systematic review and meta-analysis.
    Hum Pathol. 2026;175:106104.
    PubMed         Abstract available


    Int J Cancer

  31. HILLE J, Lorenzen S, Pauligk C, Gensch V, et al
    Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial.
    Int J Cancer. 2026;159:1817-1828.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  32. RIDNER SH, Smith DK, Kline-Quiroz CM, Jensen KM, et al
    Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2026 Aug 3:S0360-3016(26)04071.
    PubMed         Abstract available


    J Clin Oncol

  33. CHEN B, Li Z, Cheng X, Xi M, et al
    Reply to: "Tislelizumab With Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Questions on Treatment Tolerance and Follow-Up Duration" and "NRF2 Pathway Status and Maintenance Immunotherapy Exposure in EC-CRT-002".
    J Clin Oncol. 2026 Aug 5:JCO2601677. doi: 10.1200/JCO-26-01677.
    PubMed        

  34. LIANG G, Zhang Q, Yuan M
    Tislelizumab With Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Questions on Treatment Tolerance and Follow-Up Duration.
    J Clin Oncol. 2026 Aug 5:JCO2600911. doi: 10.1200/JCO-26-00911.
    PubMed        


    J Laryngol Otol

  35. LIU J, Miao Y, Lin Z, Lin Q, et al
    Prognostic Value of Tissue and Serum Laminin in Nasopharyngeal Carcinoma: A Dual-Compartment Biomarker Study with 5-Year Follow-Up.
    J Laryngol Otol. 2026 Aug 6:1-29. doi: 10.1017/S0022215126105787.
    PubMed        


    J Nucl Med

  36. CHEVALIER B, Devos L, Baillet C, Jannin A, et al
    Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.
    J Nucl Med. 2026 May 14:jnumed.125.271707. doi: 10.2967/jnumed.125.271707.
    PubMed         Abstract available


    J Oral Maxillofac Surg

  37. YASEN W, Jiang W, He K, He YN, et al
    The Prognostic Value of Preoperative Fibrinogen and Its Combination With Platelet-Lymphocyte Ratio in Oral Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2026;84:1352-1364.
    PubMed         Abstract available


    Oral Oncol

  38. DIETZE A, Zabini A, Schanne DH, Elicin O, et al
    De-escalation of radiotherapy in HPV-negative non-nasopharyngeal head and neck squamous cell carcinoma: a systematic review.
    Oral Oncol. 2026;181:108095.
    PubMed         Abstract available

  39. WU H
    Caution is warranted before omitting neck dissection after neoadjuvant chemoimmunotherapy in cT3-4N0M0 oral squamous cell carcinoma.
    Oral Oncol. 2026;181:108105.
    PubMed        

  40. LIU R, Wang Z, Yang X, He J, et al
    Health-Related quality of life (HRQoL) and health state utility values (HSUV) in patients with head and neck Cancer: A systematic review and Meta-Analysis.
    Oral Oncol. 2026;181:108097.
    PubMed         Abstract available

  41. TOPKAN E, Selek U
    Comment on Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2026;181:108096.
    PubMed        

  42. SUDARSON J
    Commentary on "Risk-benefit stratification for immune checkpoint inhibitor therapy in head and neck cancer based on immune-related adverse events and treatment discontinuation using routine clinical indicators beyond PD-L1 expression".
    Oral Oncol. 2026;181:108099.
    PubMed         Abstract available


    Otolaryngol Head Neck Surg

  43. SCUSSIATTO HO, Patel EA, Stenson KM, Al-Khudari S, et al
    Response to: Comment on "Association of Lead in Drinking Water With Head and Neck Cancer in the United States".
    Otolaryngol Head Neck Surg. 2026 Aug 7. doi: 10.1002/ohn.70370.
    PubMed        

  44. DWYER D, Vipler B
    Comment on "Association of Lead in Drinking Water With Head and Neck Cancer in the United States".
    Otolaryngol Head Neck Surg. 2026 Aug 6. doi: 10.1002/ohn.70369.
    PubMed        

  45. WEN J, Liu C, Wang Z, Pan M, et al
    Is Bilateral Neck Dissection Always Necessary for Hypopharyngeal Squamous Cell Carcinoma? Risk Factors for Occult Contralateral Metastasis.
    Otolaryngol Head Neck Surg. 2026 Aug 4. doi: 10.1002/ohn.70373.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  46. WOLFE CA, Mendes TV, Jackobs F, Bench S, et al
    Adapting the MasSpec Pen for noninvasive detection of oral cavity squamous cell carcinoma.
    Proc Natl Acad Sci U S A. 2026;123:e2603602123.
    PubMed         Abstract available


    Radiother Oncol

  47. CANTERS R, Badiu V, Reijtenbagh D, Kneepkens E, et al
    Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol.
    Radiother Oncol. 2026 Aug 4:111717. doi: 10.1016/j.radonc.2026.111717.
    PubMed         Abstract available

  48. LI Z, Yang Y, Yin X, Zheng C, et al
    Single-cell and spatial transcriptomics delineate the remodeling of esophageal squamous-cell carcinoma ecosystem following diverse therapies.
    Radiother Oncol. 2026 Aug 4:111720. doi: 10.1016/j.radonc.2026.111720.
    PubMed         Abstract available


    Thyroid

  49. PRINZI A, van Velsen EFS, Krajewska J, Kolton M, et al
    Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.
    Thyroid. 2026 Aug 3:10507256261473771. doi: 10.1177/10507256261473771.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum